The ESMO Immuno-Oncology Congress helps to increase the overall understanding of the potential of immunotherapy and its implications for clinical practice, today and in the future.
Geneva, Switzerland – 13 Dec – 16 Dec 2018
The Congress keeps oncologists up-to-date in this rapidly evolving field and is the ideal platform for all interested stakeholders. From the basics of immunotherapies to the latest research results; from understanding different treatment options to management of toxicities and interpretation of new data, the Congress builds the European community of immuno-oncology stakeholders
http://www.esmo.org/Conferences/ESMO-Immuno-Oncology-Congress-2018